Related references
Note: Only part of the references are listed.Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents
Quanhai La et al.
EUROPEAN JOURNAL OF CANCER (2010)
Interferon-λs: the modulators of antivirus, antitumor, and immune responses
Mingcai Li et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Regulation of apoptosis by type III interferons
W. Li et al.
CELL PROLIFERATION (2008)
Mesenchymal Stem Cells: An Emerging Tool for Cancer Targeting and Therapy
Vanessa Fritz et al.
CURRENT STEM CELL RESEARCH & THERAPY (2008)
IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo
Caroline Sommereyns et al.
PLOS PATHOGENS (2008)
IL-28 elicits antitumor responses against murine fibrosarcoma
Muneo Numasaki et al.
JOURNAL OF IMMUNOLOGY (2007)
Interferons α and λ inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics
Tobias Marcello et al.
GASTROENTEROLOGY (2006)
Novel interferon-λs induce antiproliferative effects in neuroendocrine tumor cells
Kathrin Zitzmann et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Antitumor activity of IFN-ℷ in murine tumor models
Atsuko Sato et al.
JOURNAL OF IMMUNOLOGY (2006)
Characterization of the mouse IFN-λ ligand-receptor system:: IFN-λs exhibit antitumor activity against B16 melanoma
A Lasfar et al.
CANCER RESEARCH (2006)
Mcl-1 interacts with truncated bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis
JG Clohessy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A comparison of the antitumor effects of interferon-α and β on human hepatocellular carcinoma cell lines
M Murata et al.
CYTOKINE (2006)
IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro
G Vitale et al.
CANCER RESEARCH (2006)
IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression
S Brand et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Biological activity of interleukins-28 and-29: Comparison with type I interferons
A Meager et al.
CYTOKINE (2005)
Fiber-modified adenovirus vectors mediate efficient gene transfer into undifferentiated and adipogenic-differentiated human mesenchymal stem cells
H Mizuguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy
H Hamada et al.
CANCER SCIENCE (2005)
Interferons, interferon-like cytokines, and their receptors
S Pestka et al.
IMMUNOLOGICAL REVIEWS (2004)
Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents
M Studeny et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Interferon-β gene therapy for cancer:: Basic research to clinical application
J Yoshida et al.
CANCER SCIENCE (2004)
Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis
M Chawla-Sarkar et al.
APOPTOSIS (2003)
IL-28, IL-29 and their class II cytokine receptor IL-28R
P Sheppard et al.
NATURE IMMUNOLOGY (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
Share Paper
